|
MechanismA.fumigatus DHODH inhibitors |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
/ Active, not recruitingPhase 1 一项在健康中国人受试者中评估Olorofim单次口服给药的药代动力学和安全性的I期研究
[Translation] A Phase I Study to Evaluate the Pharmacokinetics and Safety of Olorofim after a Single Oral Dose in Healthy Chinese Subjects
本临床试验的主要目的是在中国健康受试者中评估Olorofim单次口服给药的PK,次要目的是在中国健康受试者中评估Olorofim单次口服给药的安全性和耐受性。
[Translation] The primary objective of this clinical trial is to evaluate the PK of a single oral administration of Olorofim in healthy Chinese subjects, and the secondary objective is to evaluate the safety and tolerability of a single oral administration of Olorofim in healthy Chinese subjects.
A Phase 1 Study to Assess the Pharmacokinetics and Safety of a Single Oral Dose of Olorofim in Healthy Chinese Participants.
Start Date09 Nov 2023 |
Sponsor / Collaborator- |
A Phase 1 Study to Assess the Pharmacokinetics of Olorofim in Healthy Japanese and Caucasian Participants
Start Date27 Mar 2023 |
Sponsor / Collaborator- |
100 Clinical Results associated with A.fumigatus DHODH
100 Translational Medicine associated with A.fumigatus DHODH
0 Patents (Medical) associated with A.fumigatus DHODH